The new research chemical Methoxphenidine is a brand new NMDA Antagonist which has likely been introduced to offer an alternative to MXE.
Methoxphenidine has shown to act on dopamine transport, whilst also acting as an antagonist at the NMDA receptor.
The Advisory Council on the Misuse of Drugs (ACMD) recommends NBOMe drugs should be controlled as Class A drugs.
It further recommends the group of stimulants known as Benzofury (6-APB and 5-APB) are controlled as Class B drugs.
A wide range of decision makers, researchers and civil society activists – were invited to give an input around the new regulation.
Some are suggesting that the EU follow New Zealand, which has chosen the regulation of the market instead of prohibition.
The research chemical 5-MeO-DALT aka N,N-diallyl-5-methoxytryptamine is a psychedelic tryptamine first synthesized by Alexander Shulgin.
5-MeO-DALT is legal in the UK because the allyl group is not an alkyl group, which the law requires for a tryptamine to be illegal.